At Janus Henderson, we believe in the sharing of expert insight for better investment and business decisions.
We call this ethos Knowledge Shared.
Timely views on market events and the latest thinking from Janus Henderson.
We provide access to some of the industry’s most talented and innovative thinkers.
Find out how environmental, social and governance (ESG) considerations are embedded within our organization and investment principles.
Subscribe for relevant insights delivered straight to your inbox
Japanese Prime Minister Shinzo Abe’s resignation signifies an end to “Abenomics,” policies based on monetary easing, fiscal stimulus and structural reforms.
Investors maintaining a tech allocation should stay focused on the secular forces behind the sector’s recent impressive financial performance.
Ted Thome, CFA
Now may be the time for investors to evaluate their portfolios and prepare for the next season.
Ashwin Alankar, PhD, Myron Scholes, PhD
After the recent party conventions, the options market continues to favor a Biden victory – but does not see his chances of winning increasing.
Nick Maroutsos, Jason England, Daniel Siluk
A reflection on how the lyrics of a pop hit from 20 years ago can have some interesting overlap with today’s crisis-hit economy and markets.
Gregory Kolb, CFA
Current market extremes present shifting reward-to-risk opportunities.
Andy Acker, CFA
How COVID-19 is shifting the discourse around health care during the 2020 U.S. election.
Despite a shift in policy, the Federal Reserve will likely not have to worry about watching inflation climb above its target of averaging 2% over the long term.
Large tech companies face a shifting regulatory and geopolitical landscape; is it possible for potential policy changes to slow the sector’s strong run?
The Federal Reserve’s actions during the COVID-19 crisis have led to an almost idyllic environment to invest in corporate bonds.
May Ling Wee, CFA
A discussion of the main highlights for investors in China stocks over the first half of the year and the outlook for the rest of 2020.
Agustin Mohedas, Ph.D.
New technology and government funding are helping accelerate COVID-19 vaccine development, with potential benefits for the biotech sector over the long term.